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Summary
Calorie restriction (CR) is one of the most robust means to improve health and survival
in model organisms. CR imposes a metabolic program that leads to increased stress
resistance and delayed onset of chronic diseases, including cancer. In rodents, CR
induces the upregulation of two NADH-dehydrogenases, namely NAD(P)H:quinone oxi-
doreductase 1 (Nqo1) and cytochrome b5 reductase 3 (Cyb5r3), which provide electrons
for energy metabolism. It has been proposed that this upregulation may be responsible
for some of the beneficial effects of CR, and defects in their activity are linked to aging
and several age-associated diseases. However, it is unclear whether changes in meta-
bolic homeostasis solely through upregulation of these NADH-dehydrogenases have a
positive impact on health and survival. We generated a mouse that overexpresses both
metabolic enzymes leading to phenotypes that resemble aspects of CR including a mod-
est increase in lifespan, greater physical performance, a decrease in chronic inflamma-
tion, and, importantly, protection against carcinogenesis, one of the main hallmarks of
CR. Furthermore, these animals showed an enhancement of metabolic flexibility and a
significant upregulation of the NAD+/sirtuin pathway. The results highlight the impor-
tance of these NAD+ producers for the promotion of health and extended lifespan.
K E YWORD S
aging, calorie restriction, CYB5R3, metabolic homeostasis, NQO1
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2018 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.




wileyonlinelibrary.com/journal/acel | 1 of 13
1 | INTRODUCTION
Aging is defined as a progressive decline of intrinsic structural integ-
rity and physiological function. Variations in energy demand, dietary
requirements, and cellular energy metabolism contribute to the mul-
tiple factors that characterize the aging processes and modulate
longevity (Lopez-Otin, Blasco, Partridge, Serrano & Kroemer, 2013).
A reduction in total calorie intake, known as calorie restriction (CR),
and various forms of fasting such as intermittent fasting or fasting-
mimicking diets confer a wide range of beneficial effects toward
healthy lifespan, with robust protection against cancer (Brandhorst &
Longo, 2016; Longo & Panda, 2016). The metabolic fluctuations and
the management of cellular bioenergetics induced by fasting cycles
are slowly being unraveled and constitute an emerging area of
research aimed at developing nutritional interventions to improve
health and lifespan.
CYB5R3 and NQO1 are two NADH-dehydrogenases that play an
essential role in the redox control of metabolic homeostasis, a funda-
mental hallmark of extended longevity (Lopez-Otin et al., 2013). CR,
a robust anti-aging intervention that extends lifespan in almost all
organisms tested, is accompanied by the rescue of age-associated
decline of CYB5R3 and NQO1 function [reviewed in (de Cabo, Sien-
dones, Minor & Navas, 2009; Hyun, Hernandez, Mattson & de Cabo,
2006)]. Likewise, several pharmacological and genetical-based strate-
gies targeting these enzymes have been employed to ultimately
delay aging and age-related metabolic diseases (Calabrese, Cornelius,
Dinkova-Kostova, Calabrese & Mattson, 2010; Lee et al., 2012; Mar-
tin-Montalvo et al., 2016; Rizvi & Pandey, 2010; Varela-Lopez,
Giampieri, Battino & Quiles, 2016). CYB5R3 catalyzes a two-step
one-electron transfer reaction in which NADH is oxidized and coen-
zyme Q (CoQ) is reduced. The elongation and desaturation of fatty
acids, cholesterol biosynthesis, and hepatic drug metabolism have all
been linked to CYB5R3 (de Cabo et al., 2009). Moreover, CYB5R3
plays a critical role in nitric oxide signaling and vascular function
(Rahaman et al., 2015) and in the modulation of lipid metabolism
that contributes to healthy lifespan (Martin-Montalvo et al., 2016).
NQO1 catalyzes a two-electron quinone reduction using NADH or
NADPH as cofactor. In addition to its well-known antioxidant prop-
erties [reviewed in (Ross & Siegel, 2017)], NQO1 exerts significant
metabolic functions by conferring protection against obesity, hyper-
tension, arterial restenosis, renal injury, and neurodegenerative disor-
ders (Chhetri, King & Gueven, 2017; Hwang et al., 2009; Kim et al.,
2011; Son et al., 2015). The C609T (Pro187Ser) null polymorphism
of the NQO1 gene is associated with increased risk of complications
related to metabolic syndrome, Alzheimer’s disease, and an overall
increased risk of cancer in humans (Chhetri et al., 2017; Lajin &
Alachkar, 2013; Martinez-Hernandez et al., 2015; Ramprasath et al.,
2012). Genetic ablation of NQO1 in rodent models also increases
sensitivity to skin carcinogenesis (Iskander et al., 2005) and causes
severe dysregulation of lipid and glucose metabolism (Gaikwad, Long,
Stringer & Jaiswal, 2001). Recent evidence suggests a role of NQO1
in the modulation of the translational machinery, linking the RNA-
binding function of NQO1 with its metabolic actions (Di Francesco
et al., 2016).
In this study, we generated a mouse that is the result of the
cross between two strains overexpressing b5-reductase and NQO1
that are two NADH-quinone reductases. The offspring that resulted
from such mating are referred as “RedTg” mouse. We performed a
comprehensive analysis of molecular, physiological, and biochemical
outcomes to elucidate the influence of both NADH-dehydrogenases
in the maintenance of whole-body metabolic homeostasis and to
assess whether their upregulation would have a positive impact on
health, cancer prevention, and survival. We found that enhanced co-
expression of CYB5R3 and NQO1 mimicked some aspects of CR by
conferring health benefits and prolonged lifespan in male RedTg
mice. Importantly, RedTg mice survived significantly longer than con-
trol mice in a model of induced liver cancer.
2 | RESULTS
2.1 | Overexpression of NAD(P)H dehydrogenases
extends lifespan and impacts muscle performance
A transgenic mouse overexpressing the rat Nqo1 and Cyb5r3 genes
was created, herein referred to as RedTg. Western blot analysis con-
firmed the increased levels of NQO1 and CYB5R3 proteins in most
tissues tested from RedTg mice compared to their wild-type (Wt)
controls, with the exception of NQO1 in white adipose tissue and
CYB5R3 in kidney and liver (Figure S1). A longevity study was car-
ried out (n = 64 Wt and n = 75 RedTg mice), and the results showed
a divergence in the survival curves starting at 110 weeks of age (Fig-
ure 1a). The log-rank test indicated a 4.2% increase in mean lifespan
(p = .04, v2 = 3.9) and 4.8% extension in 20% survival (p = .01, two-
tailed t test) in RedTg vs. Wt mice (Figure 1a).
Body weight was monitored across lifespan (Figure 1b). While no
difference prior to weaning was found between the two cohorts
(6.98  0.18 g vs. 6.58  0.14 g in 16-day-old Wt and RedTg mice,
respectively), RedTg mice had lower body weight between the age
of 2 and 12 months, but were significantly heavier after 21 months
of age, as denoted by a right shift of the body weight curve com-
pared with age-matched Wt controls (Figure 1b; Figure S2a). The
switch in body weight trajectory has led us to investigate further the
phenotypic changes and potential molecular/metabolic mechanisms
that occurred at mid-life in response to Nqo1 and Cyb5r3 overex-
pression. No differences in body composition [i.e., % body fat, lean
mass, or lean-to-fat ratio] between genotypes could be detected in
14-month-old mice (Figure 1c,d; Figure S2b). We then investigated
energy expenditure using an indirect respiration calorimetry system
known as the CLAMS metabolic chamber (Martin-Montalvo et al.,
2016). Energy expenditure was calculated from O2 consumption and
CO2 generation. The resultant VCO2/VO2 ratio, known as respira-
tory exchange ratio (RER), and heat production were measured over
a 91-hr period. RedTg mice showed a trend toward higher RER dur-
ing the first (night-fed, light-fed), and these differences increased
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significantly at the third (refed) cycle (Figure 1e), indicating that
RedTg mice preferentially used carbohydrates to meet their energy
needs as compared to Wt animals. Food consumption was similar in
both groups of mice before and after the fasting period (Figure S2c,
d), as was heat production and spontaneous ambulatory activity over
the course of the fed-fasted–refed cycle (Figure S2e).
F IGURE 1 Extension of lifespan and improved health in RedTg mice. (a) Kaplan–Meier survival curve for RedTg (n = 75) and Wt (n = 64)
male mice. Only one Wt animal was censored in the lifespan study. (b) Body weight profile over the lifespan. Bars depict significant differences
in body weight between genotypes at the times indicated. Data include all live animals at each time point. (c,d) Effect of CYB5R3 and NQO1
overexpression on body composition. Lean and fat percentages were determined by nuclear magnetic resonance (NMR) in 14-month-old mice,
n = 5–8 mice per group. (e) Fourteen-month-old mice were placed into metabolic cages for the measure of respiratory exchange ratio (RER)
over a fed-fasted–refed cycle, n = 6–8 per group. (f,g,h) Influence of both NADH-dehydrogenases on physical performance. Treadmill
performance, n = 17 mice per group; time to fall from a wire hang, n = 5–6 mice per group; time to fall from an accelerating rotarod, n = 5–6
mice per group. Data are represented as the mean  SEM. *p < .05
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To investigate whether the health improvement and extension of
lifespan observed in RedTg mice could be derived from change in
insulin sensitivity, we carried out several biochemical tests. Fasting
glucose and lactate levels showed no significant differences between
the two groups of mice at 14 months of age (Figure S3a,b). Likewise,
circulating insulin levels and HOMA-IR2 index (Figure S3c,d), the oral
glucose tolerance test (OGTT) (Figure S3e,f), and the insulin toler-
ance test (ITT) (Figure S3g,h) showed similar values for RedTg and
Wt mice. These results supported the notion that upregulation of
NAD(P)H dehydrogenases did not promote changes in peripheral
glucose homeostasis in mice of this age-group.
Cardiovascular performance was then evaluated by treadmill test,
while wire hang and rotarod tests were carried out to evaluate the
combination of muscle strength with motor coordination and bal-
ance. Although both groups of animals exhibited similar treadmill
performance (Figure 1f), RedTg mice performed significantly better
on the wire hang and rotarod tests (Figure 1g,h), suggesting
enhanced overall physical fitness as compared to Wt controls.
Prominent overexpression of both NADH-dehydrogenases in
RedTg muscle (Figure S1) led us to evaluate the abundance of sev-
eral key metabolic proteins. Western blot analysis of RedTg muscle
homogenates showed significantly greater levels of glycolytic mark-
ers, such as hexokinase II (HK-II), phosphofructokinase (PFK), and
pyruvate dehydrogenase (PDH), but a decrease in lactate dehydro-
genase A (LDHA) content (Figure 2a). Densitometric analysis of
these immunoblots is depicted in Figure 2b. Upregulation of these
glycolytic markers may reflect higher aerobic glycolytic flux to sup-
ply a carbon source for the tricarboxylic acid cycle, a finding con-
sistent with the increase in RER in RedTg mice (Figure 1e). HK-II
and PFK are the main rate-controlling enzymes of glycolytic flux
while PDH activity, which catalyzes the conversion of pyruvate to
acetyl-CoA, modulates mitochondrial glucose and fatty acid fluxes.
Mitochondrial fatty acid (FA) b-oxidation is a metabolic feature pro-
moted by CR and exercise that is controlled by PGC-1a, a member
of a family of transcriptional coactivators, and the protein deacety-
lase SIRT3 (Hirschey et al., 2010; Liang & Ward, 2006). Western
blot analysis showed significant accumulation of PGC-1a and SIRT3
in muscle of RedTg mice compared to Wt controls (Figure 2c,d).
Hydroxyacyl-coenzyme A dehydrogenase (HADHSC) and acetyl-
CoA acyltransferase 2 (ACAA2) are two mitochondrial enzymes
involved in fatty acid b-oxidation, whose protein levels were sub-
stantially higher in RedTg muscles (Figure 2c,d).
Analysis of the activity of mitochondrial complexes from whole
muscle homogenates also showed a trend toward upregulation of
the activity of mitochondrial complex II, which oxidizes FADH2 that
is mainly provided by fatty acids (Table S5). Overall, these data sug-
gest enhanced motor function and muscle performance/metabolism
in RedTg mice in a CR-like fashion.
2.2 | Overexpression of NAD(P)H dehydrogenases
enhances glycolysis and impacts lipid metabolism in
the liver
Western blot analysis of RedTg liver homogenates showed signifi-
cantly greater PFK protein levels while exhibiting a lower PDH expres-
sion than did the Wt liver (Figure 3a,b). However, no differences were
observed for glucokinase (GCK), the glucose transporter GLUT-1, and
LDHA, which are involved in the uptake and conversion of glucose
F IGURE 2 Enhancement of
bioenergetics efficiency in muscle in RedTg
mice. (a) Total muscle lysates were
immunoblotted for key glycolytic enzymes
(HK-II, PFK, LDHA, and PDH). (b)
Quantification of protein levels after data
normalization with Sypro staining of a
duplicate gel. (c) Same lysates were
immunoblotted for PGC-1a, SIRT3,
ACAA2, and HADHSC. (d) Quantification
of protein levels as in panel B. Dotted line
in panels B and D depicts Wt values
arbitrarily set at 100%. Data are
represented as the mean  SEM, n = 5–7
per group. *p < .05
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(Figure 3a,b). In line with this, metabolomics analysis of RedTg livers
showed significant increase in the relative abundance of glucose and
lactate, but the intermediates glucose-6-phosphate (G-6-P), fructose-
6-phosphate (F-6-P), and 3-phosphoglycerate (3PG) were depleted
(Figure 3c). These results combined with the in vivo RER data illustrate
a shift in hepatic substrate utilization toward glucose, yielding higher
glycolysis and lactate accumulation via reduced expression, and per-
haps activity, of the PDH complex (Figure 3a,b).
F IGURE 3 Overexpression of CYB5R3
and NQO1 enhances hepatic glycolysis and
impacts hepatic lipid metabolism in RedTg
mice. (a) Abundance of key glycolytic
enzymes in total liver lysates of 14-month-
old RedTg mice. Western blotting was
carried out using primary antibodies
specific for GLUT1, GCK, PFK, LDHA, and
PDH, n = 5–7 per group. (b) Quantification
of protein levels by densitometry. A
comparable gel was stained with Sypro
(a, bottom panel) to confirm equal loading
in each lane. (c) Metabolomics analysis of
liver extracts was carried out for the
determination of glucose, lactate, G6P,
F6P, 3PG, and pyruvate. Relative
metabolite levels are depicted, n = 5–7 per
group. (d) Total liver lysates were
immunoblotted for PGC-1a, SIRT3,
ACAA2, HADHSC, and phosphorylated
ACC. (e) Quantification of protein levels
after data normalization with Sypro
staining of a duplicate gel. Dotted line
depicts Wt values arbitrarily set at 100%.
(f) Relative abundance of laureate,
palmitate, stearate, glycerol, and
monopalmitin from the liver metabolomics
analysis. Data are represented as the
mean  SEM, n = 5–7 per group. *p < .05
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In RedTg livers, the total expression level of PGC-1a and SIRT3
as well as HADHSC and ACAA2 proteins was significantly lower
compared to Wt livers, consistent with reduced hepatic lipid catabo-
lism (Figure 3d,e). Under these conditions, the pool of the inactive,
phosphorylated form of ACC was also diminished in RedTg mice
(Figure 3d,e). Metabolomics analysis showed significant depletion in
the signals associated with palmitate and stearate, two precursors of
polyunsaturated fatty acids, as well as those for glycerol and mono-
palmitin, two intermediates in the triacylglycerol synthesis (Fig-
ure 3f). These results support the notion of increased lipogenesis in
RedTg liver. The observed relative increase in laureate would be in
agreement with short-term regulation of hepatic lipogenesis by med-
ium-chain fatty acids (Geelen, 1994) (Figure 3f).
Analysis of mitochondrial complexes from whole liver homoge-
nates showed no difference in activity between the two groups of
mice (Table S5).
2.3 | Overexpression of NAD(P)H dehydrogenases
modulates NAD+ metabolism
Sustained glycolysis requires the replenishment of the cellular pool
of NAD+, a cofactor for several metabolic enzymes, including the
class III histone deacetylases known as sirtuins. Because of the
essential role of the NAD+/sirtuin pathway in the metabolic regula-
tion of aging (Grabowska, Sikora & Bielak-Zmijewska, 2017), we
hypothesized that the overexpression of NQO1 and CYB5R3, two
NAD+-producing enzymes, may affect either NAD+ metabolism, sir-
tuin expression and/or activity, or both. As expected, NAD+ and
NADP+ levels were significantly higher in RedTg vs. Wt muscle (Fig-
ure 4a), accompanied by an accumulation of SIRT1 protein and a
trend toward lower total lysine-acetylated protein levels in RedTg
muscle (Figure 4b,c). Likewise, the buildup of nicotinamide in RedTg
livers (Figure 4d) was consistent with active NAD+ consumption by
sirtuins and the transfer of reducing equivalents important for meta-
bolic use. The RedTg livers had significantly more SIRT1 protein and
lower content of total lysine-acetylated proteins compared to Wt liv-
ers (Figure 4e,f).
2.4 | RedTg mice exhibit protection against
inflammation and liver cancer
Principal component analysis (PCA) was performed to evaluate the
liver transcriptome profiles (Figure 5a). Of a total of 497 genes with
significantly modified expression, 25.5% (127/497) were upregulated
and 74.4% (370/497) downregulated in RedTg vs. Wt livers. The top
twenty upregulated and downregulated genes are shown in Tables
F IGURE 4 Overexpression of CYB5R3
and NQO1 impacts NAD metabolism. (a)
Abundance of NAD and NADP in muscles
of RedTg and Wt mice, n = 3–4 per group.
(b) Total muscle lysates were
immunoblotted for SIRT1 and total lysine-
acetylated proteins (Ac-Lys), n = 5–7 per
group. (c) Quantification of protein levels
after data normalization with Sypro
staining. (d) Relative levels of nicotinamide
in livers of RedTg and Wt mice from the
liver metabolomics analysis. n = 5–7 per
group. (e) Total liver lysates were
immunoblotted for SIRT1 and total lysine-
acetylated proteins (Ac-Lys), n = 5–7 per
group. (f) Quantification of protein levels
as in panel c. Dotted line in panels c and f
depicts Wt values arbitrarily set at 100%.
Data are represented as the mean  SEM,
*p < .05
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F IGURE 5 Overexpression of CYB5R3 and NQO1 protects against inflammation and liver cancer. (a) Principal component analysis (PCA) from
microarray RNA experiment in livers of 14-month-old RedTg and Wt mice; n = 3–4 per group. (b) Bars depict gene sets significantly upregulated
(blue) and downregulated (red) in RedTg vs. Wt mice. (c) Validation of the microarray data by quantitative RT–PCR analysis. Hepatic mRNA levels
of Tnrfs18, Il1b, Gadd45b, Tsc22d1, and Gpx1 in RedTg mice were normalized to Wt controls, n = 4–5 per group. (d) Body weight trajectories
following treatment of high-fat (HF) diet-fed mice with diethylnitrosamine (DEN). Data include all live animals at each time point. MRI analysis was
carried out 9 months after starting the DEN protocol for the measure of (e) liver volume, (f) number of liver tumors, (g) tumor volume, and (h)
tumor volume ratio, which was calculated as percent of tumor volume divided by liver volume. (i) Representative images of RedTg and Wt livers
after 9 months of DEN treatment. Bar, 10 mm. For panels e–h, Wt (n = 12), RedTg (n = 17). Data are represented as the mean  SEM. *p < .05.
(j) Kaplan–Meier survival curve for RedTg (n = 18) and Wt (n = 17) mice includes all animals at each time point until the study termination. The
surviving mice were euthanized and considered as censored (RedTg, n = 15; Wt, n = 8)
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S6 and S7. These include Cyp4a12, a member of the cytochrome
P450 superfamily of detoxifying enzymes, and the regulator of cell
cycle Rgcc. Gene Ontology (GO) term analysis in RedTg livers identi-
fied “Inflammatory Response,” “Cell Cycle,” and “Cell Proliferation”
among the pathways that were robustly downregulated, whereas
“Oxidoreductase Activity” was among the top upregulated pathways
(Figure 5b). The mRNA expression level of several transcripts associ-
ated with these pathways was measured by quantitative real-time
PCR, which included Gpx1, encoding glutathione peroxidase 1, and
Il1b, a member of the pro-inflammatory interleukin 1 cytokine family
(Figure 5c). Gpx1 mRNA expression levels were elevated while those
of Il1b and Tnfrs18, a co-stimulatory immune checkpoint molecule,
were significantly lower by ~90% in RedTg vs. Wt livers (Figure 5c).
Tsc22d1 encodes a leucine zipper transcription factor that plays a
role in tumor suppression and Gadd45b encodes a protein involved
in the regulation of growth and apoptosis. There was significant
increase in Tsc22d1 mRNA expression levels and a trend toward
lower expression for Gadd45b in response to CYB5R3 and NQO1
overexpression (Figure 5c).
The downregulation of processes involved in liver inflammation
and cell cycle progression suggests that the RedTg liver might be
protected against cancer development. To test this hypothesis, we
treated mice with a single injection of the chemical carcinogen,
diethylnitrosamine (DEN), a model of metabolic syndrome-asso-
ciated liver cancer (Park et al., 2010). Here, sixteen-day-old RedTg
and Wt mice were injected with DEN and then put on high-fat
(HF) diet from weaning to 16 months of age. For the first
7 months, the body weight gain in RedTg mice exposed to DEN
and HF diet was slower than in Wt mice receiving the same treat-
ment, after which Wt animals experienced a severe drop of body
weight while RedTg mice maintained their weight (Figure 5d). MRI
scans were acquired at the age of 9 months and revealed that
while the liver volume remained comparable between genotypes
(RedTg, 1848.2  129.1 mm3; Wt, 2115.6  220.2 mm3; p = .27)
(Figure 5e), the number and volume of liver tumors were signifi-
cantly lower in RedTg vs. Wt mice: [25.8  4.8 vs. 42.7  5.7;
p = .03] and [449.8  105.4 mm3 vs. 942.8  177.5 mm3; p = .01],
respectively (Figure 5f,g). As a result, the tumor burden, defined as
the percentage of tumor volume compared to total liver volume,
was found to be lower in DEN-treated RedTg vs. Wt mice
[21.9  4.1% vs. 40.6  5.6%; p = .01] (Figure 5h,i). Notably, when
exposed to DEN and HF diet, the Wt mice exhibited significantly
lower longevity than RedTg mice (Figure 5j).
3 | DISCUSSION
CR without malnutrition reduces the incidence of age-associated
disease and extends lifespan through mechanisms that include
improvement of insulin sensitivity and cardiometabolic benefits,
accompanied by enhanced cognitive and motor function. Skeletal
muscle adaptations to CR and exercise lead to enhanced capacity
for glucose utilization and FA oxidation (Navas-Enamorado,
Bernier, Brea-Calvo & de Cabo, 2017). Despite the lack of effects
on peripheral glucose homeostasis, bioenergetic efficiency in skele-
tal muscle was improved in response to overexpression of CYB5R3
and NQO1, mirroring a CR-like metabolic profile that was accom-
panied by enhanced muscle strength, motor coordination, and bal-
ance. Metabolic flexibility during CR is characterized by an
enhanced capacity to cycle from whole-body FA metabolism to
carbohydrate utilization immediately after feeding (Bruss, Kham-
batta, Ruby, Aggarwal & Hellerstein, 2010). Analysis of indirect
respiration calorimetry data showed significantly greater glycolytic
metabolism in RedTg mice. Metabolic reprogramming toward a
preferential use of carbohydrates was further confirmed by upreg-
ulation of glycolysis in muscle and liver. This metabolic shift in
substrate utilization was coupled with a strengthening in redox
control and tissue NAD+ homeostasis, as evidenced by greater
accumulation of NAD+ (in muscle) and nicotinamide (in liver) in
RedTg vs. Wt mice. Endogenous formation of nicotinamide can
occur directly by cleavage of NAD+ by NAD+-consuming enzymes
such as sirtuins (SIRTs), CD38, and PARPs (Canto, Menzies & Auw-
erx, 2015; Verdin, 2015). The significant accumulation of SIRT1
protein in muscle and liver extracts of RedTg mice was accompa-
nied by weaker global protein acetylation signal, possibly because
of higher SIRT1 activity as compared to Wt mice. Many lines of
evidence indicate that sirtuins mediate the effects of CR, and small
molecule SIRT1 activators confer broad health benefits likely
through SIRT1-mediated deacetylation of target proteins [reviewed
in Ref. Guarente, 2013]. Overall, our findings are in agreement
with the role of CYB5R3 and NQO1 as efficient intracellular gen-
erators of NAD+ for utilization by sirtuins (Ross & Siegel, 2017;
Shen et al., 2017), and are consistent with the notion that modula-
tion of SIRT1 and NAD+ levels represents a promising approach
for the treatment of age-associated metabolic diseases (Herranz
et al., 2010; Imai, 2010; Verdin, 2015).
It is worth mentioning that, after an initial period of weight
loss, CR mice reestablish a state of energy balance in which fat
mass is preserved or even increased to adjust FA oxidation with
its intake plus synthesis (Bruss et al., 2010). Herein, the prefer-
ence of RedTg mice for carbohydrate utilization was likely associ-
ated with higher rate of hepatic lipogenesis—using the ratio of
phospho/total form of ACC as surrogate marker—which was fur-
ther supported by the metabolomics analysis. Conversely, there
was clear reduction in key regulators of the lipid oxidation pro-
cess, including PGC-1a, SIRT3, ACAA2, and HADHSC in RedTg
livers. It has been previously reported that ad libitum-fed animals
on diets that are high in carbohydrates, but low in proteins, have
greater adiposity and the longest lifespan (Solon-Biet et al., 2014),
although the association between the intake of protein/carbohy-
drates and adiposity is still a matter of debate (Fontana et al.,
2016; Maida et al., 2016; Solon-Biet et al., 2015) including
prospective cohort studies of humans (Berryman, Agarwal, Lieber-
man, Fulgoni & Pasiakos, 2016; Pimpin, Jebb, Johnson, Wardle &
Ambrosini, 2016). Nonetheless, the maintenance of body weight
in older RedTg mice may be due to higher fat accumulation than
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in Wt controls, in agreement with our recent study that showed a
positive correlation between mouse longevity and conservation of
body fat (Mitchell et al., 2016). Although lipidomics analysis was
not performed in the current study, health improvement and
extension of lifespan have been linked to fatty acid chain elonga-
tion and desaturation both in flies and mice overexpressing
CYB5R3 (Martin-Montalvo et al., 2016).
Reduction in low-grade chronic inflammation and anticancer pro-
tection are among the CR-mediated physiological hallmarks that lead
to successful aging. Here, the tumor-promoting effects of DEN were
significantly abrogated in RedTg mice by delaying the formation of
liver cancer. The development and progression of liver cancer as well
as the relative risk of cancer-related deaths have been associated
with chronic systemic inflammation(De Pergola & Silvestris, 2013).
Interestingly, ablation of TNF signaling in mice by genetic deletion of
the type 1 TNF receptor (Tnfr1/) markedly impedes the develop-
ment of obesity-dependent liver cancer (Park et al., 2010). In our
study, overexpression of CYB5R3 and NQO1 resulted in lower hep-
atic inflammatory signature as well as a lower level of Tnrfs18
mRNA, which encodes a member of the TNF receptor superfamily.
Likewise, pathways populated with genes associated with cell prolif-
eration and cell cycle were significantly downregulated in RedTg liv-
ers, a finding that was independently validated by the analysis of
Gadd45b mRNA expression. Interestingly, reports have shown the
existence of cross talk between the TNFa-NFkB signaling pathway
and the coactivator Gadd45b (Kodama & Negishi, 2011; Tian et al.,
2011), and strong staining of GADD45b has also been detected in
multiple human cancer tissues (Hoffman & Liebermann, 2013).
Reciprocal regulation of the putative tumor suppressor gene
Tsc22d1, which leads to the suppression of Gadd45b and that of
other cancer-associated target genes (Iida, Anna, Gaskin, Walker &
Devereux, 2007), may also account for the lower rate of tumor pro-
gression in RedTg livers.
Thus, RedTg mice had a modest increase in survival, exhibited
physiological aspects of CR in the absence of reduced energy
intake, and, importantly, were protected against DEN-induced liver
carcinogenesis. Based on our results summarized in Figure 6, we
propose that these beneficial effects were conferred through two
interrelated processes: (i) protection against metabolic and oxida-
tive stress, which leads to better maintenance of redox state and
bioenergetics, and (ii) increased NADH oxidation, which promotes
sirtuin activation and suppression of inflammation and cellular pro-
liferation. In line with this, overexpression of SIRT1 confers pro-
tection against hepatic DNA damage and associated liver cancer
caused by metabolic syndrome (Herranz et al., 2010). Further
studies will be needed to unveil the molecular mechanisms of sir-
tuins in the remodeling of chromatin via epigenetic modification
of histone and nonhistone proteins [reviewed in Ref. (Hwang, Yao,
Caito, Sundar & Rahman, 2013; Xie, Zhang & Zhang, 2013)]. In
conclusion, enhancement of metabolic flexibility coupled with effi-
cient redox control and energy homeostasis underlies the positive
influence of CYB5R3 and NQO1 co-expression on health and
longevity.
4 | EXPERIMENTAL PROCEDURES
4.1 | Transgenesis, animal models, and diets
NQO1-transgenic mice overexpressing the rat Nqo1 gene (Figure S4)
and CYB5R3-Tg mice that overexpress the rat Cyb5r3 gene (Martin-
Montalvo et al., 2016) were employed to generate RedTg mice.
Group-housed mice were maintained in a room at constant tempera-
ture (20°–22°C) with 30%–70% relative humidity and 12-h light:dark
cycles. Mice were fed ad libitum on a standard diet [SD - (#110700
—Research Diets, Bethlehem, PA)]. For the longevity study, male
RedTg (n = 75) and wild-type (Wt) (n = 64) mice were employed and
their body weight was monitored monthly. The longevity study was
performed in parallel with a previous study (Martin-Montalvo et al.,
2016), and therefore, the same values for the Wt group of mice are
represented in both studies. For the diethylnitrosamine (DEN)-
induced liver cancer study, male RedTg (n = 18) and Wt (n = 17)
mice were fed a high-fat AIN-93G Purified Rodent Diet [HF diet -
(#101920 - Research Diets)] at the indicated time of the experiment,
and their body weight was measured biweekly. The composition of
SD and HF diets can be found in Tables S1 and S2. All animal proto-
cols were approved by the ACUC of the National Institute on Aging,
an AAALAC-accredited institution (protocol #277-TGB-2019).
Animals were inspected daily for health issues, and deaths were
recorded for each animal. The criteria for euthanasia of moribund
animals were based on an independent assessment by a veterinarian,
according to AAALAC guidelines, and only cases where the condition
of the animal was considered incompatible with continued survival
were represented as deaths in the curves. Animals removed at sacri-
fice for experimental procedures were treated as censored deaths.
F IGURE 6 Schematic representation of the main features
induced by CR and shared by RedTg mice overexpressing CYB5R3
and NQO1 proteins. Please note that whole-body physiology was
characterized in 14-month-old RedTg mice. FA, fatty acids; CHO,
carbohydrates
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Survival curves were plotted using the Kaplan–Meier method, which
includes all animals at each time point.
4.2 | Fasting glucose and insulin determination
A 6-h fasted protocol was used for the determination of blood glu-
cose and plasma insulin levels in mice as described in the Supporting
Information.
4.3 | Oral glucose and insulin tolerance tests (OGTT
and ITT)
OGTT and ITT were performed as previously described (Martin-
Montalvo et al., 2013). At the time points indicated, glucose was
measured in whole blood by tail venipuncture using the Ascensia
Elite glucose meter.
4.4 | Homeostasis model assessment of insulin
resistance (HOMA-IR)
Insulin resistance was estimated using the HOMA2 Calculator soft-
ware available from the Oxford Centre for Diabetes, Endocrinology,
and Metabolism Diabetes Trials Unit website as described (Levy,
Matthews & Hermans, 1998).
4.5 | Body composition
A minispec LF90 nuclear magnetic resonance (NMR) spectrometer
(Bruker Optics, Billerica, MA) was employed to acquire measure-
ments of lean, fat, and fluid masses in live mice.
4.6 | Metabolic clamps
At the age of 14 months, mouse metabolic rate during a fed-fast–
refed cycle was assessed by indirect calorimetry in open-circuit
Oxymax chambers (CLAMS; Columbus Instruments, Columbus,
OH), as previously described (Martin-Montalvo et al., 2016).
Movement (both horizontal and vertical) was monitored with light
beams, yielding counts of beam breaks for each mouse. All mice
were acclimatized to the monitoring cages for 4 hr prior to
recording.
4.7 | Physical performance tests
Various physical performance tests were performed on 14-month-
old RedTg and Wt mice according to standard procedures as
described in the Supporting Information.
4.8 | Gel electrophoresis and western blotting
Preparation of mouse liver and skeletal muscle homogenates from
14-month-old RedTg and Wt mice was followed by protein separa-
tion by gel electrophoresis and detection of specific proteins
according to standard procedures as described in the Supporting
Information. Antibodies used are presented in Table S3.
4.9 | Measurements of mitochondrial activities
Activities of NADH:coenzyme Q oxidoreductase (complex I), succi-
nate dehydrogenase (complex II), ubiquinol:cytochrome c oxidoreduc-
tase (complex III), cytochrome c oxidase (complex IV), and citrate
synthase (CS) were determined in mouse livers by spectrophotomet-
ric assays as described (Spinazzi, Casarin, Pertegato, Salviati & Angel-
ini, 2012).
4.10 | Untargeted metabolomics
Metabolomics analysis on liver extracts from 14-month-old RedTg
and Wt mice was performed at the UC Davis West Coast Metabolo-
mics Center as previously described (Mitchell et al., 2016). Normal-
ization was performed as described in the Supporting Information.
4.11 | Targeted metabolomics
Sample preparation and LCMS-based quantitative measurement of
NAD+ and NADP+ in muscle extracts from 14-month-old RedTg and
Wt mice was performed in the Department of Biochemistry, Univer-
sity of Iowa, as previously described (Trammell & Brenner, 2013).
4.12 | Gene expression
Total RNA was extracted from frozen liver tissue using TRIzol
reagent (Thermo Fisher Scientific, Waltham, MA). Total RNA concen-
tration and quality were measured by Nanodrop (Thermo Fisher,
Waltham, MA, USA) and by Agilent Bioanalyzer RNA 6000 chip (Agi-
lent, Santa Clara, CA). cDNA reverse transcription and quantitative
RT–PCR were carried out according to standard procedures as
described in the Supporting Information. The primer sequences are
presented in Table S4. Full methodological details including microar-
ray analysis are described in the Supporting Information.
4.13 | Diethylnitrosamine (DEN)-induced
hepatocellular carcinoma model
Sixteen-day-old mice were injected intraperitoneally with DEN at a
dose of 5 mg/kg body weight, and, at 21 days of age, they were
switched to a HF diet for 16 months as previously described (Mar-
tin-Montalvo et al., 2016). Magnetic resonance imaging (MRI) was
performed on 9-month-old mice to determine liver and tumor vol-
umes as described below. At the conclusion of the study, the surviv-
ing mice were euthanized.
4.14 | Magnetic resonance imaging
Mice were anesthetized using 1%–2% isoflurane in oxygen at a flow rate
of 1.5 lpm and placed in a Bruker Biospec 7T/30 cm MRI scanner
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(Bruker Biospin, Ettlingen, Germany) equipped with a 72-mm resonator
coil (Bruker). Full methodological details for the detection and quantifica-
tion of liver tumors are described in the Supporting Information.
4.15 | Statistical analysis
Unless otherwise stated, statistical comparisons between genotypes
were performed by two-tailed Student’s t test using Excel 2010 (Micro-
soft Corp., Redmond, WA, USA). For survival studies, a log-rank statisti-
cal test was used. Analyses were performed using GraphPad Prism v. 6
(GraphPad Software, Inc., La Jolla, CA). In all experiments, results are
represented as the mean  SEM, with p ≤ .05 considered significant.
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